Changes

9 bytes added ,  10:32, 6 July 2016
no edit summary
Line 3: Line 3:  
! Disease Name !! MESH header !! Disease Id !! Prognosis !! Gene Name !! Band !! Cytogenetic Aberration !! Non-cytogenetic Characteristic !! Gene Entrez ID !! Cytoband !! Aberration !! Aberration Label !! Described Effect !! Bearing !! Therapy Type !! Therapy Name !! Therapy Class !! Therapy Id !! Diagnostic, Prognostic, Therapy related !! pubmed ids
 
! Disease Name !! MESH header !! Disease Id !! Prognosis !! Gene Name !! Band !! Cytogenetic Aberration !! Non-cytogenetic Characteristic !! Gene Entrez ID !! Cytoband !! Aberration !! Aberration Label !! Described Effect !! Bearing !! Therapy Type !! Therapy Name !! Therapy Class !! Therapy Id !! Diagnostic, Prognostic, Therapy related !! pubmed ids
 
|-
 
|-
| [[Non Small Cell Lung Cancer]]||Carcinoma, Non-Small-Cell Lung||D002289||||MET||7q31.2||Amplification||||4233||7q31.2||Gain||MET Amplification||Targeted Therapies May Be Available (i.e. Crizotinib) ||pos||drug||Crizotinib||||||Therapy||21716144, 26628860
+
| [[Non Small Cell Lung Cancer]]||Carcinoma, Non-Small-Cell Lung||D002289||||MET||7q31.2||Amplification||||4233||7q31.2||Gain||MET Amplification||Targeted Therapies May Be Available (i.e. Crizotinib) ||pos||drug||Crizotinib||||||Therapy||PMID 21716144 PMID 26628860
 
|-
 
|-
 
| Gastrointestinal Stromal Tumors||Gastrointestinal Stromal Tumors||D046152||||KIT||4q12||Amplification||||3815||4q12||Gain||KIT Amplification||Targeted Therapies May Be Available (i.e. Tyrosine Kinase Inhibitors); Recurring in Gastrointestinal Stromal Tumor; Imatinib Mylate Treatment||pos||drug||Imatinib Mesylate||||||Therapy||26098203
 
| Gastrointestinal Stromal Tumors||Gastrointestinal Stromal Tumors||D046152||||KIT||4q12||Amplification||||3815||4q12||Gain||KIT Amplification||Targeted Therapies May Be Available (i.e. Tyrosine Kinase Inhibitors); Recurring in Gastrointestinal Stromal Tumor; Imatinib Mylate Treatment||pos||drug||Imatinib Mesylate||||||Therapy||26098203